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Members of the Bcl-2 family proteins are best known for their roles in apoptosis regulation. In this issue of
Developmental Cell, Popgeorgiev et al. (2011) have uncovered a new, nonapoptotic role for a Bcl-2 homolog
during early embryogenesis in zebrafish.The Bcl-2 family proteins have been
studied extensively for their important
roles in apoptosis regulation (Youle and
Strasser, 2008). More recent data,
however, suggested the involvement of
at least some members of this protein
family in processes unrelated to apoptosis
(Danial et al., 2010; Rolland and Conradt,
2010). This intriguing phenomenon, where
a single protein may have multiple func-
tions, also referred to as moonlighting
(Jeffery, 2003), is not entirely unexpected;
why not ‘‘reuse’’ them for additional
purposes? In an elegant and detailed
study that appears in this issue of
Developmental Cell, Gillet and colleagues
demonstrate this idea, describing a new
role of the zebrafish Bcl-2 homolog,
Nrz, in modulating calcium fluxes and
consequent cytoskeleton dynamics in
the gastrulating embryo (Popgeorgiev
et al., 2011).
In animal development and homeo-
stasis, unwanted or potentially dangerous
cells are often eliminated by a gene-
encoded cell suicide program called
apoptosis. A key feature of apoptosis is
the activation of special proteases called
caspases, a process tightly regulated by
several distinct evolutionary conserved
pathways (Song and Steller, 1999).
In vertebrates,mitochondrial resident pro-
teins, collectively known as the intrinsic
pathway, are released to the cytosol
upon apoptosis induction, playing a
crucial role in the activation of caspases.
Central to this pathway is the release of
the respiratory chain protein cytochrome
c (cyt c) from the mitochondrial intermem-
brane space into the cytoplasm, where it
forms the apoptosome complex together
with the adaptor protein Apaf-1 and the
initiator caspase-9. Consequently, cas-
pase-9 can further activate effectorcaspases, such as caspase-3, which,
in turn, cleave hundreds of cellular
protein substrates, ultimately leading to
apoptosis (Salvesen and Riedl, 2008).
The Bcl-2 family proteins are the bona
fide regulators of the mitochondrial
apoptotic pathway, consisting of at least
12 proteins inmammals, generally divided
into three groups of opposing apoptotic
activities (Youle and Strasser, 2008). It
is commonly thought that proapoptotic
family members, such as Bax and Bak,
form pores in membranes and thus are
crucial for inducing mitochondrial outer
membrane permeabilization (MOMP)
and the subsequent release of cyt c
and other apoptogenic proteins. The anti-
apoptotic family members, including
Bcl-2 and the mammalian Nrz homolog
Bcl-2L10, inhibit this process by amecha-
nism that remains unclear and largely
controversial. Finally, a divergent group
of so-called BH3-only proteins promote
Bax and Bak activation by binding and in-
hibiting Bcl-2 and its paralogs, or through
direct binding to Bax and Bak (Youle and
Strasser, 2008).
The idea that some proteins can moon-
light has been known for some time (Jeff-
ery, 2003). Furthermore, nonapoptotic
cellular roles were recently suggested for
some Bcl-2 family proteins—in particular,
in regulating mitochondrial metabolism,
dynamics, and cellular homeostasis
(Danial et al., 2010; Rolland and Conradt,
2010). However, one way or another,
these ‘‘day jobs’’ are all intimately related
to apoptosis, generally representing an-
other facet of this process or simply the
other side of the same coin. Significantly,
the work of Popgeorgiev et al. (2011)
provides in vivo evidence that Nrz, an
antiapoptotic Bcl-2 family member, plays
an apoptosis-independent role duringDevelopmental Celepiboly, the process where the vegetally
localized yolk is enclosed by migrating
blastomeres from the animal pole during
early embryonic development in zebra-
fish. In support of this idea, knockdown
of nrzwith antisensemorpholinos resulted
in epiboly arrest with no significant cas-
pase-3 activation. Furthermore, expres-
sion of p35, the caspase inhibitor protein
from baculovirus, was incapable of
restoring epiboly progression in these
mutants. Of note, ectopic expression of
Bax during the same embryonic stages
caused excessive cell death and embry-
onic lethality, both of which were rescued
by coexpression of p35, indicating that the
apoptotic machinery can be activated
during these early embryonic stages.
Additional support for a nonapoptotic
role of Nrz in epiboly comes from a
previous report by the same group
showing that treatment of nrz knockdown
embryos with the pan caspase inhibitor
z-VAD-fmk and coinjection of bax anti-
sense morpholino both failed to prevent
epiboly arrest and early embryonic
mortality (Arnaud et al., 2006). Finally,
through mutagenesis, functional domain
exchanging to achieve ectopic subcellular
localization, and immunofluorescence
studies, the authors rigorously demon-
strate that the action of Nrz required
for epiboly progression stems from the
endoplasmic reticulum (ER) and not the
mitochondria, as would have been ex-
pected if the role of Nrz during epiboly
were to regulate apoptosis.
How does ER-localized Nrz, then,
promote epiboly progression? Popgeor-
giev et al. (2011) provide several lines of
evidence for a role of Nrz in modulating
calcium (Ca2+) release from the ER. In
short, they report a significant accumula-
tion of cytosolic Ca2+ in the marginall 20, May 17, 2011 ª2011 Elsevier Inc. 575
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Previewsregion between the progressing blasto-
meres and the yolk (a belt-like layer of
a membrane-enclosed group of nuclei
located at top of the yolk cell, also dubbed
the yolk syncytial layer [YSL]), which is the
primary region of Nrz expression during
epiboly stages. Likewise, increasing
cytosolic Ca2+ by other means caused
similar defects as in nrz knockdown
embryos. The authors’ data also offer
a plausible mechanism by which Nrz
mediates Ca2+ release from the ER.
Following a recent report on the interac-
tion between Bcl-2 and an IP3-gated
Ca2+ channel (i.e., IP3R) on the ER (Rong
et al., 2009), the authors demonstrate
that Nrz can similarly bind to and inhibit
the opening of IP3R1, thus blocking
Ca2+ release into the cytosol. Further-
more, treatment of nrz knockdown
embryos with an IP3R inhibitor prevented
Ca2+ increase and significantly reduced
early mortality of these mutants. In their
conclusion, the authors present data
showing that nrz knockdown alters the
actin cytoskeleton in the yolk cell, which
causes premature constriction of the
margin, epiboly arrest, and death of the
embryo, effects that are probably due to
the premature phosphorylation of the
myosin light chain (MLC) by the Ca2+/
calmodulin-dependent kinase MLCK.
The discovery of a genetic requirement
for a Bcl-2 family protein in morphoge-
netic cell movements during early
embryogenesis provides a significant
advance in our understanding of cell life576 Developmental Cell 20, May 17, 2011 ª2and death during animal development,
but some unanswered questions remain.
Perhaps the most intriguing question in
relation to the moonlighting role of Nrz is
how the switch between its distinct func-
tions occurs. The work by Popgeorgiev
et al. (2011) implies that it is the ‘‘ER
versus mitochondrial’’ localization of Nrz
that matters. However, localization of
Bcl-2 family members to the ER and
Ca2+ fluxes are also associated with
apoptosis (Rong et al., 2009). Further-
more, the authors report that downregula-
tion of nrz expression also results in
dissipation of mitochondrial membrane
potential (Dcm) and release of cyt c, both
of which are characteristics of apoptosis.
Therefore, the switch may involve addi-
tional mechanisms. It is attractive to
suggest that the initiator caspase-9 may
be activated in nrz knockdown embryos,
while the downstream effector caspases
remain inactive. Indeed, the caspase
inhibitor p35 is known to inhibit effector
caspases, but not initiator caspases.
Interestingly, three studies in Drosophila
indicate a role of the initiator but not
effector caspases in the regulation of
actin dynamics during cellular morpho-
genesis and cell motility (reviewed in Fein-
stein-Rotkopf and Arama, 2009). It will be
interesting to determine whether these
processes have been conserved in evolu-
tion between the fly and the fish.
To conclude, the work by Popgeorgiev
et al. (2011) not only illuminates another
important regulatory aspect of Bcl-2011 Elsevier Inc.family proteins but also extends the grow-
ing list of apoptosis-associated factors,
including the effector caspases them-
selves, which function in nonapoptotic,
vital, cellular processes during develop-
ment (Feinstein-Rotkopf and Arama,
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